Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
7.12
+0.14 (2.01%)
At close: Mar 9, 2026, 4:00 PM EDT
7.03
-0.09 (-1.33%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $44.06 million as of March 9, 2026. Its market cap has decreased by -43.07% in one year.
Market Cap
44.06M
Enterprise Value
-29.12M
1-Year Change
-43.07%
Ranking
Category
Stock Price
$7.12
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $44.06M, a decrease of -92.04%. That is a compound annual growth rate of -37.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 42.95M | -25.11% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 45.14M |
| Estrella Immunopharma | 44.98M |
| NextCure | 43.43M |
| Apollomics | 43.05M |
| Telomir Pharmaceuticals | 42.98M |
| Lite Strategy | 41.45M |
| OnKure Therapeutics | 41.32M |
| Palatin Technologies | 40.78M |